openPR Logo
Press release

CASwell Secures Products Against MDS Attacks

08-29-2019 12:52 PM CET | IT, New Media & Software

Press release from: CASwell

CASwell Secures Products Against MDS Attacks

CASwell Secures Products Against MDS Attacks

New firmware updates for network devices & servers against ZombieLoad, RIDL & Fallout

Taipei, Taiwan - August 27th, 2019 - CASwell Inc., a leading manufacturer of innovative and high-performance server solutions for SD-WAN (uCPE/vCPE) and network security systems, announced today that most of its network devices and servers have received updates for their firmware or BIOS making them secure against any malicious attacks based on MDS vulnerabilities. With these updates customers and users can breathe a sigh of relief as they are now safe with the theoretical threats of ZombieLoad, RIDL and Fallout not to be worried about anymore.

In May of this year Intel and independant researchers reported about a new group of vulnerabilities inside Intel processors called "Microarchitectural Data Sampling" (MDS). All four of these techniques use side-channel attacks to be able to access data of other processes that they are not supposed to see, making it especially critical in data centers and cloud services running virtual machines. These exploitations - called ZombieLoad, RIDL (Rogue In-Flight Data Load), Store-to-Leak Forwarding and Fallout - are very complex to implement real-world, can't target specific data to gather and not known to be practically used be any attacker so far. Nevertheless, Intel provided timely processor microcode updates (MCU) and now CASwell has implemented these MCUs into the largest part of its product stack.

According to Intel, the MCUs mitigating MDS have minimal performance impact on PC systems but can vary under data center workloads depending on software and resource utilization.

CASwell has provided new BIOS and firmware versions including the MCUs by Intel for systems based on the current CAR-6010, CAR-5050, CAR-4040, CAR-3080, CAR-2080 and other rackmounts, the CAD-0260 desktop series, the CAF-0250 fanless series and even older models like the CAR-1030 or the CAD-0235. Other isolated CASwell products are currently being validated and will get their respective updates as soon as possible.

For more information regarding specific models or any other questions please contact your local CASwell representative or sales.

Find out more about "Side Channel Vulnerability MDS" at
Amsterdam University reports about RIDL and Fallout at

CASwell Inc.
No. 242, Bo'ai Street
Shulin District
New Taipei City, 238

Frank Schraeer
Product Specialist & Marketing

CASwell, Inc. was founded in 2007 by a group of engineers with a desire to create dynamic system solutions for embedded applications. While CASwell is a young company, it has proved itself to its customers with advanced technology, professional service and superior design and manufacturing capability by delivering a great portfolio of solutions based on Linux®. In 2014, the well-known IPC manufacturer Ennoconn Corporation (subsidiary of Foxconn Technology Group) decided to invest in CASwell, becoming the largest shareholder. CASwell has since become the subsidiary of Ennoconn, a member of Foxconn Technology Group. CASwell is dedicated to providing its customers with an unparalleled one-stop shopping experience for their network security and management needs. Find out more on the official website:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CASwell Secures Products Against MDS Attacks here

News-ID: 1827816 • Views: 424

More Releases from CASwell

CASwell Releases CAF-026D - Classic SD-WAN, VCPE And Security Solution Reloaded
Fanless And Compact Network System Leveraging Updated Intel Atom Processor C-Series (Denverton-NS Refresh) For Higher Performance. 2022/6/28 - CASwell, a leading manufacturer of innovative and high-performance SD-WAN (uCPE/vCPE) and network systems, introduces the new CAF-026D fanless networking desktop system with Intel's upgraded Atom Processor C-Series (Denverton-NS Refresh) as a successor to its widely used CAF-0260/0262/0264/026B systems using the previous generation of Denverton-NS CPUs. With enhanced technology, the CAF-026D is an even
CASwell Announces Diverse CAR-5056 Versions Of High-End Network Server Switch At …
Different Configurations Of Sophisticated And Programmable Server System For Different Target Markets 2022/1/25 - CASwell, a leading manufacturer of innovative and high-performance SD-WAN (uCPE/vCPE) and network security systems, has announced the immediate and long-term future of its CAR-5056 network server switch during a presentation at Intel's Edge to Cloud Conference in Taiwan. This high-end dual Intel Xeon system with programmable Intel Barefoot Tofino Ethernet switch was announced last year and generated
CASwell Announces CAF-0100 - Fanless Network Appliance Based On Intel Atom "Elkh …
Energy-Efficient Desktop System Supporting Wi-Fi And 5G Or LTE Mobile Networks For SMB And SOHO CASwell, a leading manufacturer of innovative and high-performance SD-WAN (uCPE/vCPE) and network systems, announces the new CAF-0100, a fanless multi-networking appliance in desktop format. The CAF-0100 offers superior energy efficiency and high performance in a compact form factor with its new Intel Atom processor and up to six high-speed Ethernet ports plus supporting Wi-Fi and mobile
CASwell Offers CAR-5050 As Intel Select Solution For Visual Cloud Delivery Netwo …
Appliance Based On Dual 2nd Gen Intel Xeon Scalable Processors Is Verified And Ready For Deployment As Content Delivery Network Server (2021/11/23 ) CASwell, a leading manufacturer of innovative and high-performance SD-WAN (uCPE/vCPE) and network systems, is proud to announce that the outstanding CAR-5050 rackmount server has been officially verified by Intel as an Intel Select Solution for Visual Cloud Delivery Networks (VCDN). With two 2nd Gen Intel Xeon Scalable processors,

All 5 Releases

More Releases for MDS

Healthcare M2M Market to See Huge Growth by 2025 | Athenahealth, McKesson, Amazi …
The Latest research study released by HTF MI “Global Healthcare M2M Market” with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research
Myeloidysplastic Syndromes (MDS) – Epidemiology Insights (2016-2028)
Myeloidysplastic syndromes (MDS) can be described as a group of hematologic malignancies, that occurr due to abnormality in blood-forming cells in the bone marrow. It is a rare blood cancer and can be mild, moderate or severe, in terms of severity. Download the sample report @ This syndrome can be classified into three main types: MDS with single lineage dysplasia wherein a single type of blood cell appears abnormal; multilineage
Top Scenario: Healthcare CRM Market By Key Players: Allscripts, Cerner, e-MDs, C …
Qyresearchreports include new market research report Healthcare CRM to its huge collection of research reports. Healthcare CRM, also known as Healthcare Relationship Management, is a broadly used term for a Customer relationship management system In 2017, the global Healthcare CRM market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global
Myelodysplastic Syndrome (MDS) Treatment Market Industry Forecast till 2025
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells called as blasts, get stored in the bone marrow and blood and obstruct the natural function of the hematological system which results in depletion of healthy red blood cells, platelets, and white blood cells. Myelodysplastic syndrome is usually seen in geriatric population and more
Global Myelodysplastic Syndrome (MDS) Therapeutics Market Size, Trends, Analysis …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “2018-2025 Report on Global and United States Myelodysplastic Syndrome (MDS) Therapeutics Market Status and Forecast, by Players, Types and Applications” which provides an outlook of current market growth as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR near XX% during 2018-2025. The report studies myelodysplastic syndrome therapeutics in global market,
Myelodysplastic Syndrome (MDS) Treatment Market - Global Industry Insights 2025
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around